{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-007277","form_type":"8-K","ticker":"CNTN","cik":"0001861657","company_name":"Canton Strategic Holdings, Inc.","filed_at":"2026-02-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.595494+00:00","generated_at":"2026-05-16T02:09:55.725971+00:00","sec_items":["5.03","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Tharimmune rebrands to Canton Strategic Holdings, ticker changes to CNTN; unveils digital asset treasury strategy","bullets":["Corporate name changed to Canton Strategic Holdings, Inc.; new NASDAQ ticker CNTN effective Feb. 18, 2026.","Company executes digital asset treasury strategy including Canton Coin acquisition and operation of a Super Validator.","Previously closed $545M private placement in Nov. 2025; recent $55M registered offering completed for growth capital.","Board appointments include former CFTC Commissioner Jill Sommers and DRW's William Wiley to deepen institutional expertise.","Company remains first publicly traded firm supported by Canton Foundation, also retains clinical-stage biotech R&D."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-007277","json":"https://secwatch.observer/filing/0001493152-26-007277.json","markdown":"https://secwatch.observer/filing/0001493152-26-007277.md","text":"https://secwatch.observer/filing/0001493152-26-007277.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1861657/000149315226007277/0001493152-26-007277-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1861657/000149315226007277/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T02:09:55.725971+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"59c218ec3ca14a297199259b42a24d9e3a526d83","claim":"Canton Strategic Holdings, Inc.: Bylaws amended to reflect name change and current size of Board of Directors (effective 2026-02-18).","evidence_excerpt":"The Company also amended and restated its bylaws on February 18, 2026 to reflect the Name Change and reflect the current size of the Board of Directors.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1861657/000149315226007277/0001493152-26-007277-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2026-02-18"}],"fact_type":"governance_change"},{"claim_id":"f885640c4d8d581b09fe662745e62cef9e43c13d","claim":"Canton Strategic Holdings, Inc.: Name change from Tharimmune, Inc. to Canton Strategic Holdings, Inc., approved via amended and restated certificate of incorporation (effective 2026-02-09).","evidence_excerpt":"On February 18, 2026, Tharimmune, Inc. (the “ Company ”) changed its corporate name to “Canton Strategic Holdings, Inc.,” pursuant to an amended and restated certificate of incorporation filed with the Delaware Secretary of State on February 9, 2026","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1861657/000149315226007277/0001493152-26-007277-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2026-02-09"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}